Clinical Trial Update: Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury. [Phase 4]

View source ↗

Summary

Pfizer-sponsored Phase 4 trial evaluating growth hormone replacement for adults with growth hormone deficiency after traumatic brain injury has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Traumatic Brain Injury

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Pfizer | Conditions: Brain Injuries | Phase 4 | Status: WITHDRAWN